Emitwise vs Nocomed: Pricing and Ratings Compared (2026)
Entry prices and free plans as read on each vendor's pricing page, and user ratings as published on review sites, for Emitwise and Nocomed side by side. This page compares data; it is not a hands-on review.
On the data: On the data below the two are close or not directly comparable, so we do not name a winner for this pair.
Short on time? Here's the quick answer
Based on published vendor pricing and features and on public review data, here's who should pick what:
Emitwise
Empowering businesses to achieve end-to-end decarbonization through supply chain engagement and carbon accounting.
Best for you if:
- • You want comprehensive solution for Scope 3 emissions management
Nocomed
Sustainability platform and training for life sciences and healthcare supply chains.
Best for you if:
- • You want specifically designed for the complex life sciences and healthcare sector
| At a Glance | ||
|---|---|---|
Starts at | Not published | Not published |
Category | ESG Reporting Carbon Tracking | Sustainability & ESG Analytics |
Rating | n/a | n/a |
Free plan | No | No |
Choose Emitwise or Nocomed?
Choose Emitwise if
- You want comprehensive solution for Scope 3 emissions management
- You want empowers procurement teams to drive decarbonization
- You work in ESG reporting, not sustainability & ESG
Choose Nocomed if
- You want specifically designed for the complex life sciences and healthcare sector
- You want helps organizations gain competitive advantage as preferred suppliers
- You work in sustainability & ESG, not ESG reporting
In-Depth Analysis
Emitwise
Empowering businesses to achieve end-to-end decarbonization through supply chain engagement and carbon accounting.
Strengths
- Pro: Comprehensive solution for Scope 3 emissions management
- Pro: Empowers procurement teams to drive decarbonization
- Pro: Provides expert support for complex carbon accounting tasks
- Pro: Facilitates access to renewable energy solutions globally
- Pro: Offers real-time visibility into supplier progress
Weaknesses
- Con: No longer available as a standalone product
- Con: Requires integration into the broader Green Project suite50 platform
Key features
Nocomed
Sustainability platform and training for life sciences and healthcare supply chains.
Strengths
- Pro: Specifically designed for the complex life sciences and healthcare sector.
- Pro: Helps organizations gain competitive advantage as preferred suppliers.
- Pro: Simplifies complex supply chain tracking and reporting.
- Pro: Provides expert-led training to build internal sustainability knowledge.
- Pro: Focuses on meaningful reduction projects and compliance with regulations like NHS mandates.
Weaknesses
- Con: Specific pricing details are not publicly available.
Key features
Key Takeaways
Emitwise
- Choose if you want empowering businesses to achieve end-to-end decarbonization through supply chain engagement and carbon accounting
Nocomed
- Choose if you want sustainability platform and training for life sciences and healthcare supply chains
What the data shows
On the data below the two are close or not directly comparable, so we do not name a winner for this pair.
Criteria: user rating (only above 20 reviews on both sides, gap of 0.2 or more), entry price (only on the same billing basis), free plan. How we rate
Frequently Asked Questions
How do Emitwise and Nocomed compare in 2026?
On the data below the two are close or not directly comparable, so we do not name a winner for this pair.
What are Emitwise and Nocomed used for?
Emitwise: Empowering businesses to achieve end-to-end decarbonization through supply chain engagement and carbon accounting. Nocomed: Sustainability platform and training for life sciences and healthcare supply chains.
What does Emitwise cost vs Nocomed?
Emitwise has no public paid-plan price on file. Nocomed has no public paid-plan price on file.
What's the main difference between Emitwise and Nocomed?
Emitwise's main strength: comprehensive solution for Scope 3 emissions management. Nocomed's main strength: specifically designed for the complex life sciences and healthcare sector.